Extendicare Inc provides care and services for seniors in Canada. The company offers long term care services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management and consulting services to third-party owners. It also provides third-party liability insurance products in the United States.
Read More…
Industry, Sector and Symbol
Industry Long-Term Care Facilities
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone905-470-4000
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$1.13 billion
Profitability
Miscellaneous
Employees23,000
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable
Extendicare (TSE:EXE) Frequently Asked Questions
What is Extendicare's stock symbol?
Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE."
How often does Extendicare pay dividends? What is the dividend yield for Extendicare?
Extendicare declared a monthly dividend on Tuesday, November 26th. Stockholders of record on Monday, December 16th will be paid a dividend of 0.04 per share on Monday, December 16th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 5.63%. The ex-dividend date of this dividend is Tuesday, November 26th. View Extendicare's Dividend History.
When is Extendicare's next earnings date?
What price target have analysts set for EXE?
5 analysts have issued 12 month price targets for Extendicare's stock. Their forecasts range from C$8.50 to C$10.00. On average, they anticipate Extendicare's stock price to reach C$9.00 in the next year. This suggests a possible upside of 5.6% from the stock's current price. View Analyst Price Targets for Extendicare.
What is the consensus analysts' recommendation for Extendicare?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Extendicare.
Has Extendicare been receiving favorable news coverage?
Media stories about EXE stock have been trending somewhat negative on Saturday, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Extendicare earned a daily sentiment score of -1.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the near future. View News Stories for Extendicare.
Who are some of Extendicare's key competitors?
What other stocks do shareholders of Extendicare own?
Who are Extendicare's key executives?
Extendicare's management team includes the folowing people:
- Ms. Jillian E. Fountain, VP of Investor Relations
- Ms. Elaine E. Everson, VP of Corp. Devel.
- Dr. Michael R. Guerriere, CEO, Pres & Director (Age 54)
- Mr. David E. Bacon, Sr. VP & CFO
- Mr. Brandon Leigh Parent, VP, Gen. Counsel & Corp. Sec.
How do I buy shares of Extendicare?
Shares of EXE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Extendicare's stock price today?
One share of EXE stock can currently be purchased for approximately C$8.52.
How big of a company is Extendicare?
What is Extendicare's official website?
How can I contact Extendicare?
The company can be reached via phone at 905-470-4000.
MarketBeat Community Rating for Extendicare (TSE EXE)
MarketBeat's community ratings are surveys of what our community members think about Extendicare and other stocks. Vote "Outperform" if you believe EXE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXE will underperform the S&P 500 over the long term. You may vote once every thirty days.
